Roberto Cairoli

26PUBLICATIONS
126CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 12, 2026
The Germline SH2B3rs111340708 Splicing Variant Drives Intron Retention and Protein Instability by Impacting Clinical Outcomes in Core Binding Factor AML.

|Mar 14, 2026
A Modified-Delphi Consensus on the Management of Patients with FLT3-Mutated AML.

Jacopo Olivieri, Emanuele Angelucci, Roberto Cairoli

|Jan 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia.

Michela Ansuinelli, Nadia Peragine, Maria Stefania De Propris

|Dec 05, 2025
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Nov 26, 2025
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.

Nicola Polverelli, Caterina Zerbi, Maria Grazia Benevento

|Sep 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.

Fabio Guolo, Luana Fianchi, Maria Paola Martelli

Pageof 5

Frequent Collaborators

6 joint publications

Alessandra Trojani

6 joint publications

Alessandro Beghini

5 joint publications

Patrizia Chiusolo

5 joint publications

Adriano Venditti